ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Wenrun Cai
Matched on ORCID iD 0000-0003-4243-4571; OpenAlex author ID A5103088092. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. First author DOI 10.1136/gutjnl-2024-333638↗
- ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis. Co-author DOI 10.1038/s41416-022-01927-y↗
- PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.05.021↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chuntao Gao · 3 shared papers, 2021–2025 · strength 0.44
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Tiansuo Zhao · 3 shared papers, 2021–2025 · strength 0.44
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Shengyu Yang · 2 shared papers, 2022–2025 · strength 0.33
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Xugang Sun · 2 shared papers, 2021–2025 · strength 0.31
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Jihui Hao · 2 shared papers, 2021–2025 · strength 0.31
- Paper Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and par… DOI 10.1136/gutjnl-2024-333638↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Fanjie Jin · 2 shared papers, 2021–2022 · strength 0.24
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Chongbiao Huang · 2 shared papers, 2021–2022 · strength 0.24
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Xiuchao Wang · 2 shared papers, 2021–2022 · strength 0.24
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Song Gao · 2 shared papers, 2021–2022 · strength 0.24
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Jing Liu · 2 shared papers, 2021–2022 · strength 0.24
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. DOI 10.1016/j.canlet.2021.05.021↗
- Danqi Fu · 1 shared paper, 2025 · strength 0.20
- Haorui Li · 1 shared paper, 2025 · strength 0.20
- Zhe Liu · 1 shared paper, 2022 · strength 0.13
- Jihui Hao · 1 shared paper, 2022 · strength 0.13
- Huizhi Sun · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.